INTERNATIONAL REMOTE IMAGING SYSTEMS INC /DE/
8-K, 1999-10-15
LABORATORY ANALYTICAL INSTRUMENTS
Previous: INTERNATIONAL REMOTE IMAGING SYSTEMS INC /DE/, 8-K, 1999-10-15
Next: NIKE INC, 10-Q, 1999-10-15



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934



       Date of report (Date of earliest event reported): October 11, 1999


                   INTERNATIONAL REMOTE IMAGING SYSTEMS, INC.
               (Exact Name of Registrant as Specified in Charter)


         DELAWARE                        1-9767                  94-2579751
(State or Other Jurisdiction          (Commission              (IRS Employer
     of Incorporation)                File Number)           Identification No.)


9162 ETON AVENUE, CHATSWORTH, CALIFORNIA                           91311
(Address of Principal Executive Offices)                         (Zip Code)


       Registrant's telephone number, including area code: (818) 709-1244


<PAGE>   2


Item 5.  Other Events.

         On October 11, 1999, the Registrant issued a press release announcing
that its arbitration with Digital Imaging Technologies, Inc., the former owner
of its Perceptive Scientific Instruments genetic analysis business, resulted in
an award to the Registrant of $132,500, a copy of which is attached as Exhibit
99 hereto and incorporated herein by reference.


                                       2
<PAGE>   3


                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                             INTERNATIONAL REMOTE IMAGING
                                               SYSTEMS, INC.



Dated:  October 15, 1999                     By: /s/ MARTIN S. McDERMUT
                                                --------------------------------
                                                Martin S. McDermut
                                                Vice President - Finance and
                                                Administration, Chief Financial
                                                Officer and Secretary


                                       3
<PAGE>   4


                                  Exhibit Index

No.              Document
- ---              --------

99               Press Release dated October 11, 1999


                                       4


<PAGE>   1




[IRIS GRAPHIC]                                                      NEWS RELEASE
- --------------------------------------------------------------------------------
CONTACTS:  MARTIN S. MCDERMUT, VP FINANCE & ADMINISTRATION, CFO
           818-709-1244 OR
           ROBERT FROST, ECOM CONSULTANTS
           212-391-9475                                    FOR IMMEDIATE RELEASE
- --------------------------------------------------------------------------------


                   IRIS awarded $132,500 by arbitration panel

         CHATSWORTH, CA, October 11, 1999 -- International Remote Imaging
Systems, Inc. or IRIS, (AMEX: IRI), a leading manufacturer and worldwide
marketer of automated in vitro diagnostic (IVD) imaging systems used to enhance
productivity and improve outcomes in genetics, urinalysis and cytology,
announced today that its arbitration with Digital Imaging Technologies, Inc.
(DITI), the former owner of its Perceptive Scientific Instruments (PSI) genetic
analysis business, resulted in an award to IRIS of $132,500.

         The arbitration was conducted under the auspices of the American
Arbitration Association. The arbitration panel found that while certain
representations, warranties and covenants in the purchase agreement for the
transaction had been breached by DITI, the panel found, for most part, these did
not result in damage to IRIS.

         IRIS designs, develops, manufactures and markets IVD imaging systems
based on its patented and proprietary AIM technology for automating microscopic
procedures performed in hospital and reference clinical laboratories and
genetics laboratories, worldwide. Its major product lines are The Yellow IRIS(R)
family of urinalysis workstations, the PowerGene(TM) line of cytogenetic
analyzers and the StatSpin line of centrifugal specimen preparation devices.


                                   * * * * * *


                                       5


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission